TNFSF15 and systemic sclerosis: TL1A, alone or in combination with IL-23, stimulated peripheral blood mononuclear cells (PBMCs) to produce IL-17 in autoimmune diseases, such as psoriasis vulgaris (PV) (49, 50), systemic sclerosis (SSc) (51), IBD (52).